News related to Viread (Tenofovir Disoproxil) and/or conditions it is approved for
Europe Clears Tenofovir Alafenamide (Vemlidy) for Chronic HBV
Source: Medscape Gastroenterology Headlines [2017.01.13]
The efficacy of once-daily Vemlidy is similar to that of tenofovir disoproxil (Viread) with fewer bone and renal side effects, the company says.
Medscape Medical News
FDA OKs HIV 'Quad' Pill
Source: MedPage Today Product Alert [2012.08.28]
WASHINGTON -- The FDA has approved Stribild, the four-drug combination of elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, for once-daily treatment of HIV in adults who have never received HIV treatment.